vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and GENESCO INC (GCO). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $616.2M, roughly 1.5× GENESCO INC). GENESCO INC runs the higher net margin — 0.9% vs 0.7%, a 0.2% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 3.3%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-31.5M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -8.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Genesco Inc. is an American publicly owned specialty retailer of branded footwear and accessories and is a wholesaler of branded and licensed footwear based in Nashville, Tennessee. Founded back in 1924 as Jarman Shoe Company, a footwear manufacturer, the company changed its name to General Shoe Corporation in 1933, and became a public company in 1939. By 1957, its stock would be included in the first S&P 500 Index. The company took its current name, Genesco—an acronym derived from its earlie...
ASTH vs GCO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $616.2M |
| Net Profit | $6.6M | $5.4M |
| Gross Margin | — | 46.8% |
| Operating Margin | 1.9% | 1.4% |
| Net Margin | 0.7% | 0.9% |
| Revenue YoY | 42.9% | 3.3% |
| Net Profit YoY | 184.4% | 128.3% |
| EPS (diluted) | $0.12 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $616.2M | ||
| Q3 25 | $956.0M | $546.0M | ||
| Q2 25 | $654.8M | $474.0M | ||
| Q1 25 | $620.4M | $745.9M | ||
| Q4 24 | $665.2M | $596.3M | ||
| Q3 24 | $478.7M | $525.2M | ||
| Q2 24 | $486.3M | $457.6M | ||
| Q1 24 | $404.4M | $739.0M |
| Q4 25 | $6.6M | $5.4M | ||
| Q3 25 | $373.0K | $-18.5M | ||
| Q2 25 | $9.4M | $-21.2M | ||
| Q1 25 | $6.7M | $34.4M | ||
| Q4 24 | $-7.8M | $-18.9M | ||
| Q3 24 | $16.1M | $-10.0M | ||
| Q2 24 | $19.2M | $-24.3M | ||
| Q1 24 | $14.8M | $27.2M |
| Q4 25 | — | 46.8% | ||
| Q3 25 | — | 45.8% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.9% | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 47.3% | ||
| Q1 24 | — | 46.3% |
| Q4 25 | 1.9% | 1.4% | ||
| Q3 25 | 2.0% | -2.6% | ||
| Q2 25 | 3.1% | -5.9% | ||
| Q1 25 | 3.3% | 6.2% | ||
| Q4 24 | 0.1% | 1.7% | ||
| Q3 24 | 5.9% | -2.0% | ||
| Q2 24 | 6.2% | -7.0% | ||
| Q1 24 | 7.5% | 5.0% |
| Q4 25 | 0.7% | 0.9% | ||
| Q3 25 | 0.0% | -3.4% | ||
| Q2 25 | 1.4% | -4.5% | ||
| Q1 25 | 1.1% | 4.6% | ||
| Q4 24 | -1.2% | -3.2% | ||
| Q3 24 | 3.4% | -1.9% | ||
| Q2 24 | 3.9% | -5.3% | ||
| Q1 24 | 3.7% | 3.7% |
| Q4 25 | $0.12 | $0.50 | ||
| Q3 25 | $0.01 | $-1.79 | ||
| Q2 25 | $0.19 | $-2.02 | ||
| Q1 25 | $0.14 | $3.16 | ||
| Q4 24 | $-0.14 | $-1.76 | ||
| Q3 24 | $0.33 | $-0.91 | ||
| Q2 24 | $0.40 | $-2.23 | ||
| Q1 24 | $0.31 | $2.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $27.0M |
| Total DebtLower is stronger | — | $89.5M |
| Stockholders' EquityBook value | $779.3M | $513.8M |
| Total Assets | $2.2B | $1.5B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $27.0M | ||
| Q3 25 | $463.4M | $41.0M | ||
| Q2 25 | $342.1M | $21.7M | ||
| Q1 25 | $260.9M | $34.0M | ||
| Q4 24 | $290.8M | $33.6M | ||
| Q3 24 | $350.3M | $45.9M | ||
| Q2 24 | $327.7M | $19.2M | ||
| Q1 24 | $337.3M | $35.2M |
| Q4 25 | — | $89.5M | ||
| Q3 25 | — | $71.0M | ||
| Q2 25 | — | $121.0M | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $100.1M | ||
| Q3 24 | — | $77.8M | ||
| Q2 24 | — | $59.4M | ||
| Q1 24 | — | $34.7M |
| Q4 25 | $779.3M | $513.8M | ||
| Q3 25 | $775.5M | $506.4M | ||
| Q2 25 | $765.5M | $522.2M | ||
| Q1 25 | $745.4M | $547.0M | ||
| Q4 24 | $712.7M | $516.9M | ||
| Q3 24 | $704.6M | $532.6M | ||
| Q2 24 | $678.9M | $548.5M | ||
| Q1 24 | $653.5M | $571.2M |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-12.9M |
| Free Cash FlowOCF − Capex | $-6.0M | $-31.5M |
| FCF MarginFCF / Revenue | -0.6% | -5.1% |
| Capex IntensityCapex / Revenue | 0.3% | 3.0% |
| Cash ConversionOCF / Net Profit | -0.44× | -2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $23.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $-12.9M | ||
| Q3 25 | $10.0M | $86.3M | ||
| Q2 25 | $90.9M | $-101.0M | ||
| Q1 25 | $16.6M | $117.0M | ||
| Q4 24 | $-10.9M | $-23.1M | ||
| Q3 24 | $34.0M | $27.7M | ||
| Q2 24 | $23.2M | $-33.7M | ||
| Q1 24 | $6.0M | $118.3M |
| Q4 25 | $-6.0M | $-31.5M | ||
| Q3 25 | $7.4M | $71.7M | ||
| Q2 25 | $89.5M | $-119.9M | ||
| Q1 25 | $13.6M | $103.3M | ||
| Q4 24 | $-13.5M | $-36.2M | ||
| Q3 24 | $31.7M | $19.8M | ||
| Q2 24 | $20.4M | $-40.1M | ||
| Q1 24 | $5.6M | $107.8M |
| Q4 25 | -0.6% | -5.1% | ||
| Q3 25 | 0.8% | 13.1% | ||
| Q2 25 | 13.7% | -25.3% | ||
| Q1 25 | 2.2% | 13.8% | ||
| Q4 24 | -2.0% | -6.1% | ||
| Q3 24 | 6.6% | 3.8% | ||
| Q2 24 | 4.2% | -8.8% | ||
| Q1 24 | 1.4% | 14.6% |
| Q4 25 | 0.3% | 3.0% | ||
| Q3 25 | 0.3% | 2.7% | ||
| Q2 25 | 0.2% | 4.0% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 2.2% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.6% | 1.4% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | -0.44× | -2.41× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 3.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | 4.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
GCO
| Journeys Group Segment | $376.7M | 61% |
| Schuh Group Segment | $123.8M | 20% |
| Johnston And Murphy Group Segment | $81.2M | 13% |
| Genesco Brands Segment | $34.6M | 6% |
| Store Restructuring | $3.9M | 1% |
